一种胞壁酰二肽类似物对免疫受损小鼠抵抗力的刺激作用。
Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
作者信息
Osada Y, Mitsuyama M, Matsumoto K, Une T, Otani T, Ogawa H, Nomoto K
出版信息
Infect Immun. 1982 Sep;37(3):1285-8. doi: 10.1128/iai.37.3.1285-1288.1982.
Abstract
L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, enhanced resistance against Escherichia coli and Candida albicans infections in aged mice and younger adult mice whose defense mechanism(s) had been depressed by X-ray irradiation or by treatment with cyclophosphamide.
摘要
L18 - 丙氨酸 - 胞壁酰二肽（L18 - MDP[Ala]）是胞壁酰二肽的一种合成衍生物，可增强老年小鼠以及防御机制因X射线照射或环磷酰胺处理而受到抑制的年轻成年小鼠对大肠杆菌和白色念珠菌感染的抵抗力。
相似文献
1
Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
Infect Immun. 1982 Sep;37(3):1285-8. doi: 10.1128/iai.37.3.1285-1288.1982.
2
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
Infect Immun. 1982 Jul;37(1):292-300. doi: 10.1128/iai.37.1.292-300.1982.
3
Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
Infect Immun. 1983 Mar;39(3):1029-40. doi: 10.1128/iai.39.3.1029-1040.1983.
4
Stimulation of non-specific resistance to infection by muroctasin.
Arzneimittelforschung. 1988 Jul;38(7A):969-76.
5
Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
Infect Immun. 1982 Jan;35(1):105-10. doi: 10.1128/iai.35.1.105-110.1982.
6
Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice.
Vaccine. 1995 Oct;13(14):1300-5. doi: 10.1016/0264-410x(95)00041-x.
7
[Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Biull Eksp Biol Med. 1985 Aug;100(8):221-3.
8
Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
Agents Actions. 1987 Oct;22(1-2):144-50. doi: 10.1007/BF01968830.
9
Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
Bull Exp Biol Med. 2008 May;145(5):623-5. doi: 10.1007/s10517-008-0157-8.
10
Activation of immune responses by muroctasin.
Arzneimittelforschung. 1988 Jul;38(7A):976-7.
引用本文的文献
1
Translation of peptidoglycan metabolites into immunotherapeutics.
Clin Transl Immunology. 2019 Nov 29;8(12):e1095. doi: 10.1002/cti2.1095. eCollection 2019.
2
Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine.
Infect Immun. 1983 Nov;42(2):618-22. doi: 10.1128/iai.42.2.618-622.1983.
3
Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.
Infection. 1984 May-Jun;12(3):230-4. doi: 10.1007/BF01640913.
4
Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages.
Infect Immun. 1984 May;44(2):445-51. doi: 10.1128/iai.44.2.445-451.1984.
5
Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
Infect Immun. 1983 Mar;39(3):1029-40. doi: 10.1128/iai.39.3.1029-1040.1983.
6
Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.
Infection. 1985;13 Suppl 2:S251-5. doi: 10.1007/BF01644439.
7
Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.
Cancer Immunol Immunother. 1986;23(1):41-5. doi: 10.1007/BF00205553.
8
Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 beta.
Agents Actions. 1988 Jun;24(1-2):130-6. doi: 10.1007/BF01968091.
9
Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice.
Antimicrob Agents Chemother. 1992 Jan;36(1):167-71. doi: 10.1128/AAC.36.1.167.
本文引用的文献
1
The effect of whole-body x irradiation on the bactericidal activity of phagocytic cells. I. Survival of Pseudomonas aeruginosa within phagocytes from peritoneal exudates of mice.
J Infect Dis. 1959 Jan-Feb;104(1):13-9. doi: 10.1093/infdis/104.1.13.
2
The influence of immunization and total body x-irradiation on intracellular digestion by peritoneal phagocytes.
J Immunol. 1956 Mar;76(3):192-9.
3
The effect of ionizing radiation on phagocytosis and the bactericidal power of the blood. II. The effect of radiation on ingestion and digestion of bacteria.
J Exp Med. 1955 Mar 1;101(3):275-90. doi: 10.1084/jem.101.3.275.
4
Infectious complications associated with hairy cell leukemia.
J Infect Dis. 1981 May;143(5):639-43. doi: 10.1093/infdis/143.5.639.
5
Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
Infect Immun. 1981 Feb;31(2):716-22. doi: 10.1128/iai.31.2.716-722.1981.
6
Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.
Infect Immun. 1981 May;32(2):748-58. doi: 10.1128/iai.32.2.748-758.1981.
7
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.
J Infect Dis. 1981 May;143(5):644-54. doi: 10.1093/infdis/143.5.644.
8
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
Infect Immun. 1982 Jul;37(1):292-300. doi: 10.1128/iai.37.1.292-300.1982.
9
The use of four-drug combination chemotherapy (D.A.V.E.) in the treatment of advanced Wilms' tumour.
Cancer Chemother Pharmacol. 1981;5(4):211-5. doi: 10.1007/BF00434386.
10
Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.
J Exp Med. 1980 Dec 1;152(6):1659-69. doi: 10.1084/jem.152.6.1659.
Zotero 插件